Econ and Finance - 28 Jul 2022

Can an HIV drug beat COVID?

Subscribe to keep reading.

Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.

Already a subscriber? Log in.

On Monday, China's drug regulator (NMPA) conditionally approved a domestically made HIV drug for treating COVID-19 patients.

Some context: The drug, Azvudine, produced by Zhengzhou-based Genuine Biotech, was originally approved for treating HIV-1 infections in July 2021.

Monday's approval mak...


Your subscription doesn't include access to this content. Upgrade your account to access.

Change your plan